25
Participants
Start Date
January 22, 2018
Primary Completion Date
October 23, 2018
Study Completion Date
November 20, 2018
Molidustat (BAY85-3934)
Starting dose of molidustat once daily (OD) will be titrated based on the subject's Hb (Hemoglobin) response
Houshikai Kano hospital, Kasuya-gun
Matsunami General Hospital, Hashima-gun
Asahikawa-Kosei General Hospital, Asahikawa
Ishikari Hospital, Ishikari
Itami Kidney Clinic, Noboribetsu
Souen Central Hospital, Sapporo
Takasago Seibu Hospital, Takasago
Japanese Red Cross Koga Hospital, Koga
Mito Kyodo General Hospital, Mito
Tokiwa Clinic, Totte
Tsuchiura Beryl Clinic, Tsuchiura
Kikuchi Medical Clinic, Tsukuba
Japanese Red Cross Ishinomaki Hospital, Ishinomaki
Iida Hospital, Iida
Toyonaka Keijinkai Clinic, Toyonaka
Kodaira Kitaguchi Clinic, Kodaira
Medical corporation association Shunshin-kai Inage hospital, Chiba
Fukuoka Renal Clinic, Fukuoka
Ohmiya Chuo General Hospital, Saitama
Yamagata Tokushukai Hospital, Yamagata
Lead Sponsor
Bayer
INDUSTRY